Receptor-regulated smads in TGF-β signaling

Frontiers in Bioscience

Volumn 8, Issue SUPPL., 2003, Pages

  Liu, Fang ^a,b  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Cancer; Cell Cycle; Cytokine; Review; SARA; Signal Transduction; Smad; Smurf; TGF ; Transcriptional Regulation; Tumor Suppressor

Indexed keywords

CELL CYCLE PROTEIN; DNA BINDING PROTEIN; MEMBRANE PROTEIN; MEMBRANE RECEPTOR; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; SMAD PROTEIN; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEIN; SMAD2 PROTEIN, HUMAN; SMAD3 PROTEIN, HUMAN; SMAD4 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

BIOACCUMULATION; CANCER INHIBITION; CELL CYCLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DNA BINDING; GENE FUNCTION; GENETIC CODE; HUMAN; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PATHOPHYSIOLOGY; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RECEPTOR UPREGULATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; TUMOR SUPPRESSOR GENE; UBIQUITINATION; AMINO ACID SEQUENCE; ANIMAL; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY;

DROSOPHILA MELANOGASTER; MAMMALIA;

AMINO ACID SEQUENCE; ANIMALS; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 3142775116     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/1149     Document Type: Review

References (272)

1. A B Roberts & M B Sporn: The transforming growth factor-betas. In: Peptide growth factors and their receptors. Eds: Sporn M B, Roberts A B, Springer-Verlag, Heidelberg, Germany 419-472 (1990)
2. Massagué J.: The transforming growth factor-β family. Annu. Rev. Cell Biol 6, 597-641 (1990)
3. Heldin C-H., K. Miyazono & P. ten Dijke: TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 39, 465-471 (1997)
4. Massagué J.: TGF-β signal transduction. Annu Rev Biochem 67, 753-791 (1998)
5. Whitman M.: Smads and early developmental signaling by the TGF-β superfamily. Genes Dev 12, 2445-2462 (1998)
6. Roberts A.B.: TGF-beta signaling from receptors to the nucleus. Microbes Infect 1, 1265-1273 (1999)
7. Patterson G.I. & R.W. Padgett: TGF beta-related pathways. Roles in Caenorhabditis elegans development. Trends Genet 16, 27-33 (2000)
8. Wrana J.L.: Regulation of Smad activity. Cell 100, 189-192 (2000)
9. Massague J., S.W. Blain & R.S. Lo: TGF-beta signaling in growth control, cancer, and heritable disorders. Cell 103, 295-309 (2000)
10. Derynck R., R.J. Akhurst & A. Balmain: Multiple roles of TGF-β signaling in tumor inhibition and cancer progression. Nat Genet 29,117-29 (2001)
11. Miyazono K., K. Kusanagi & H. Inoue: Divergence and convergence of TGF-beta/BMP signaling. J Cell Physiol 187, 265-76 (2001)
12. ten Dijke P., M.J. Goumans, F. Itoh & S. Itoh: Regulation of cell proliferation by Smad proteins. J Cell Physiol. 191, 1-16 (2002)
13. Massague J. & Y.-G. Chen: Controlling TGF-beta signaling. Genes Dev 14, 627-44 (2000)
14. Attisano L. & J.L. Wrana: Signal transduction by the TGF-beta superfamily. Science 296,1646-1647 (2002)
15. Macias-Silva M., S. Abdollah, P.A. Hoodless, R. Pirone, L. Attisano & J.L. Wrana: MADR2 is a substrate of the TGF-beta receptor and phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224 (1996)
16. Zhang Y., X.-H. Feng, R.-Y. Wu & R. Derynck: Receptor-associated Mad homologs synergize as effectors of the TGF-beta response. Nature 383, 168-172 (1996)
17. Abdollah S., M. Macias-Silva, T. Tsukazaki, H. Hayashi, L. Attisano & J.L.Wrana: TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J Biol Chem 272, 27678-27685 (1997)
18. Souchelnytskyi S., K. Tamaki, U. Engstrom, C. Wernstedt, P. ten Dijke & C.-H. Heldin: Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J Biol Chem 272, 28107-28115 (1997)
19. Hoodless P.A., T. Haerry, S. Abdollah, M. Stapleton, M.B. O'Connor, L. Attisano & J.L. Wrana: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 85, 489-500 (1996)
20. Kretzschmar M., F. Liu, A. Hata, J. Doody & J. Massague: The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev 11, 984-995 (1997)
21. Lagna G., A. Hata, A. Hemmati-Brivanlou & J. Massagué: Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways. Nature 383, 832-836 (1996)
22. Liu F., C. Pouponnot & J. Massague: Dual role of the Smad4/DPC4 tumor suppressor in TGFbeta-inducible transcriptional complexes. Genes Dev 11, 3157-3167 (1997)
23. Zhou S., P. Buckhaults, L. Zawel, F. Bunz, G. Riggins, J.L. Dai, S.E. Kern, K.W. Kinzler & B. Vogelstein: Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells. Proc Natl Acad Sci USA 95, 2412-2416 (1998)
24. Hayashi H., S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone Jr, J.L.Wrana & D. Falb: The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89,1165-1173 (1997)
25. Nakao A., M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, C.-H. Heldin & P. ten Dijke: Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631-635 (1997)
26. Imamura T., M. Takase, A. Nishihara, E. Oeda, J. Hanai, M. Kawabata & K. Miyazono: Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389, 622-626 (1997)
27. Hata A., G. Lagna, J. Massagué & A. Hemmati-Brivanlou: Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev 12, 186-197 (1998)
28. Nagarajan R.P., J. Zhang, W. Li & Y. Chen: Regulation of Smad7 promoter by direct association with Smad3 and Smad4. J Biol Chem 274, 33412-33418 (1999)
29. von Gersdorff G., K. Susztak, F. Rezvani, M. Bitzer, D. Liang & E.P. Bottinger: Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta. J Biol Chem 275,11320-11326 (2000)
30. Denissova N.G., C. Pouponnot, J. Long, D. He & F. Liu: Transforming growth factor beta-inducible independent binding of SMAD to the Smad7 promoter. Proc Natl Acad Sci USA 97, 6397-6402 (2000)
31. Brodin G., A. Ahgren, P. ten Dijke, C.-H. Heldin & R. Heuchel: Efficient TGF-beta induction of the Smad7 gene requires cooperation between AP-1, Sp1, and Smad proteins on the mouse Smad7 promoter. J Biol Chem 275, 29023-29030 (2000)
32. Ishida W., T. Hamamoto, K. Kusanagi, K. Yagi, M. Kawabata, K. Takehara, T.K. Sampath, M. Kato & K. Miyazono: Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter. J Biol Chem 275, 6075-6079 (2000)
33. Takase M., T. Imamura, T.K. Sampath, K. Takeda, H. Ichijo, K. Miyazono & M. Kawabata: Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem Biophys Res Commun 244, 26-29 (1998)
34. Massagué J. & D. Wotton: Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 19, 1745-1754 (2000)
35. Derynck R., Y. Zhang & X.H. Feng: Smads: transcriptional activators of TGF-beta responses. Cell 95, 737-740 (1998)
36. Liu X., Y. Sun, R.A. Weinberg & H.F. Lodish: Ski/Sno and TGF-beta signaling. Cytokine Growth Factor Rev 12,1-8 (2001)
37. Takenoshita S., A. Mogi, M. Nagashima, K. Yang, K. Yagi, A. Hanyu, Y. Nagamachi, K. Miyazono & K. Hagiwara: Characterization of the MADH2/Smad2 gene, a human Mad homolog responsible for the transforming growth factor-beta and activin signal transduction pathway Genomics 48, 1-11 (1998)
38. Shi Y., Y.F. Wang, L. Jayaraman, H. Yang, J. Massagué & N.P. Pavletich: Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-beta signaling. Cell 94, 585-594 (1998)
39. Yagi K., D. Goto, T. Hamamoto, S. Takenoshita, M. Kato & K. Miyazono: Alternatively spliced variant of Smad2 lacking exon 3 - Comparison with wild-type Smad2 and Smad3. J Biol Chem 274, 703-709 (1999)
40. Dennler S., S. Huet & J.M. Gauthier: A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene 18, 1643-1648 (1999)
41. Shi Y.: Structural insights on Smad function in TGF-beta signaling. Bioessays 23, 223-232 (2001)
42. Feng X.H. & R. Derynck: A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling activity. EMBO J 16, 3912-3922 (1997)
43. Lo R.S., Y.-G. Chen, Y. Shi, N. Pavletich & J. Massagué: The L3 loop: A structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J 17, 996-1005 (1998)
44. Chen Y.-G., A. Hata, R.S. Lo, D. Wotton, Y. Shi, N. Pavletich & J. Massagué: Determinants of specificity in TGF-beta signal transduction. Genes Dev 12, 2144-2152 (1998)
45. Huse M., T.W. Muir, L. Xu, Y.-G. Chen, J. Kuriyan & J. Massagué: The TGF-beta receptor activation process: an inhibitor- to substrate- binding switch. Mol Cell 8, 671-682 (2001)
46. Shi Y., A. Hata, R. Lo, J. Massagué & N.P. Pavletich: A structural basis for mutational inactivation of the tumour suppressor Smad4. Nature 388, 87-93 (1997)
47. Wu G., Y.-G. Chen, B. Ozdamar, C.A. Gyuricza, P.A. Chong, J.L. Wrana, J. Massagué & Y. Shi: Structural basis of Smad2 recognition by the Smad anchor for receptor activation. Science 287, 92-97 (2000)
48. Wu J.W., M. Hu, J. Chai, J. Seoane, M. Huse, C. Li, D.J. Rigotti, S. Kyin, T.W. Muir, R. Fairman, J. Massagué & Y. Shi: Crystal structure of a phosphorylated Smad2: Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol Cell 8,1277-1289 (2001)
49. Tsukazaki T., T.A. Chiang, A.F. Davison, L. Attisano & J.L. Wrana: SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95, 779-791 (1998)
50. Qin B.Y., S.S. Lam, J.J. Correia & K. Lin: Smad3 allostery links TGF-beta receptor kinase activation to transcriptional control. Genes Dev 16,1950-1963 (2002)
51. Moustakas A. & C.H. Heldin: From mono- to oligo-Smads: the heart of the matter in TGF-beta signal transduction. Genes Dev 16,1867-1871 (2002)
52. Qin B.Y., B.M. Chacko, S.S. Lam, M.P. de Caestecker, J.J. Correia & K. Lin: Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol Cell 8, 1303-1312 (2001)
53. Chacko B.M., B. Qin, J.J. Correia, S.S. Lam, M.P. de Caestecker & K. Lin: The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat Struct Biol 8, 248-253 (2001)
54. Wrana J.L.: Phosphoserine-dependent regulation of protein-protein interactions in the Smad pathway. Structure 10, 5-7 (2002)
55. Kawabata M., H. Inoue, A. Hanyu, T. Imamura & K. Miyazono: Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 17, 4056-4065 (1998)
56. Wu J.W., R. Fairman, J. Penry & Y. Shi: Formation of a stable heterodimer between Smad2 and Smad4. J Biol Chem 276, 20688-20694 (2001)
57. Jayaraman L. & J. Massagué: Distinct oligomeric states of SMAD proteins in the transforming growth factor-beta pathway. J Biol Chem 275, 40710-40717 (2000)
58. Correia J.J., B.M. Chacko, S.S. Lam & K. Lin: Sedimentation studies reveal a direct role of phosphorylation in Smad3:Smad4 homo- and heterotrimerization. Biochemistry 40, 1473-1482 (2001)
59. Dumas J.J., E. Merithew, E. Sudharshan, D. Rajamani, S. Hayes, D. Lawe, S. Corvera & D.G. Lambright: Multivalent endosome targeting by homodimeric EEA1. Mol Cell 8, 947-958 (2001)
60. Miura S., T. Takeshita, H. Asao, Y. Kimura, K. Murata, Y. Sasaki, J.I. Hanai, H. Beppu, T. Tsukazaki, J.L. Wrana, K. Miyazono & K. Sugamura: Hgs (Hrs), a FYVE domain protein, is involved in Smad signaling through cooperation with SARA. Mol Cell Biol 20, 9346-9355 (2000)
61. Hocevar B.A., A. Smine, X.X. Xu & P.H. Howe: The adaptor molecule Disabled-2 links the transforming growth factor β receptors to the Smad pathway. EMBO J 20, 2789-2801 (2001)
62. Xu X.X., W. Yang, S. Jackowski & C.O. Rock: Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product. J Biol Chem 270, 14184-14191 (1995)
63. Pawson T. & J.D. Scott: Signaling through scaffold, anchoring, and adaptor proteins. Science 278, 2075-2080 (1997)
64. Furuhashi M., K. Yagi, H. Yamamoto, Y. Furukawa, S. Shimada, Y. Nakamura, A. Kikuchi, K. Miyazono & M. Kato: Axin facilitates Smad3 activation in the transforming growth factor-beta signaling pathway. Mol Cell Biol 21, 5132-5141 (2001)
65. Razani B., X.L. Zhang, M. Bitzer, G. von Gersdorff, E.P. Böttinger & M.P. Lisanti: Caveolin-1 regulates transforming growth factor (TGF)-β/SMAD signaling through an interaction with the TGF-β type I receptor. J Biol Chem 276, 6727-6738 (2001)
66. Harris B.Z. & W.A. Lim: Mechanism and role of PDZ domains in signaling complex assembly. J Cell Sci 114, 3219-3231 (2001)
67. Shoji H., K. Tsuchida, H. Kishi, N. Yamakawa, T. Matsuzaki, Z. Liu, T. Nakamura & H. Sugino: Identification and characterization of a PDZ protein that interacts with activin type II receptors. J Biol Chem 275,5485-5492 (2000)
68. Tsuchida K., T. Matsuzaki, N. Yamakawa, Z. Liu & H. Sugino: Intracellular and extracellular control of activin function by novel regulatory molecules. Mol Cell Endocrinol 180, 25-31 (2001)
69. Blobe G.G., X. Liu, S.J. Fang, T. How & H.F. Lodish: A novel mechanism for regulating transforming growth factor β (TGF-β) signaling: Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein, GIPC. J Biol Chem 276, 39608-39617 (2001).
70. Datta P.K., A. Chytil, A.E. Gorska & H.L. Moses: Identification of STRAP, a novel WD domain protein in transforming growth factor-beta signaling. J Biol Chem 273, 34671-34674 (1998)
71. Datta P.K. & H.L. Moses: STRAP and Smad7 synergize in the inhibition of transforming growth factor β signaling. Mol Cell Biol 20, 3157-3167 (2000)
72. Dong C., Z. Li, R. Alvarez Jr, X.-H. Feng & P.J. Goldschmidt- Clermont: Microtubule binding to Smads may regulate TGFβ activity. Mol Cell 5, 27-34 (2000)
73. Sasaki A., Y. Masuda, Y. Ohta, K. Ikeda & K. Watanabe: Filamin associates with Smads and regulates transforming growth factor-β signaling. J Biol Chem 276, 17871-17877 (2001)
74. Wurthner J.U., D.B. Frank, A. Felici, H.M. Green, Z. Cao, M.D. Schneider, J.G. McNally, R.J. Lechleider & A.B. Roberts: Transforming growth factor-β receptor-associated protein 1 is a Smad4 chaperone. J Biol Chem 276, 19495-19502 (2001)
75. Mattaj I.W. & L. Englmeier: Nucleocytoplasmic transport: the soluble phase. Annu Rev Biochem 67, 265-306 (1998)
76. Gorlich D. & U. Kutay: Transport between the cell nucleus and the cytoplasm. Annu Rev Cell Dev Biol 15, 607-660 (1999)
77. Xiao Z., X. Liu, Y.I. Henis & H.F. Lodish: A distinct nuclear localization signal in the N terminus of Smad 3 determines its ligand-induced nuclear translocation. Proc Natl Acad Sci USA 97, 7853-7858 (2000)
78. Hata A., R.S. Lo, D. Wotton, G. Lagna & J. Massague: Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature 388, 82-87 (1997)
79. Xiao Z., X. Liu & H.F. Lodish: Importin mediates nuclear translocation of Smad3. J Biol Chem 275, 23425-23428 (2000)
80. Kurisaki A., S. Kose, Y. Yoneda, C.-H. Heldin & A. Moustakas: Transforming growth factor-β induces nuclear import of Smad3 in an importin-β1 and Ran-dependent manner. Mol Biol Cell 12, 1079-1091 (2001)
81. Moustakas A., S. Souchelnytskyi & C.H. Heldin: Smad regulation in TGF-beta signal transduction. J Cell Sci 114, 4359-4369 (2001)
82. Xiao Z., N. Watson, C. Rodriguez & H.F. Lodish: Nucleocytoplasmic shuttling of Smadl conferred by its nuclear localization and nuclear export signals. J Biol Chem 276, 39404-39410 (2001)
83. Xu L., Y.-G. Chen & J. Massagué: The nuclear import function of Smad2 is masked by SARA and unmasked by TGFβ-dependent phosphorylation. Nat Cell Biol 2, 559-562 (2000)
84. Xu L, Y. Kang, S. Col & J. Massagué: Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol Cell 10, 271-282 (2002)
85. Baker J. & R.M. Harland: A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes & Dev 10, 1880-1889 (1996)
86. Pierreux C. E., F.J. Nicolas & C.S. Hill: Transforming growth factor β-independent shuttling of Smad4 between the cytoplasm and nucleus. Mol Cell Biol 20, 9041-9054 (2000)
87. Inman G.J., F.J. Nicolas & C.S. Hill: Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol Cell 10, 283-294 (2002)
88. Zawel L., J. Dai, P. Buckhaults, S. Zhou, K. Kinzler, B. Vogelstein & S. Kern: Human Smad3 and Smad4 are sequence-specific transcription activators. Mol Cell 1, 611-617 (1998)
89. Yingling J., M. Datto, C. Wong, J. Frederick, N. Liberati & X.F. Wang. Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein. Mol Cell Biol 17, 7019-7028 (1997)
90. Dennler S., S. Itoh, D. Vivien, P. ten Dijke, S. Huet & J.M. Gauthier: EMBO J 11, 3091-3100 (1998)
91. Song C.-Z., T.E. Siok & T.D. Gelehrter: Smad4/DPC4 and Smad3 mediate transforming growth factor-beta (TGF-beta) signaling through direct binding to a novel TGF-beta responsive element in the human plasminogen activator inhibitor-1 promoter. J Biol Chem 273, 29287-29290 (1998)
92. Stroschein S.L., W. Wang & K. Luo: Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor-beta induced Smad-dependent transcriptional activation. J Biol Chem 274, 9431-9441 (1999)
93. Hua X., X. Liu, D.O. Ansari & H.F. Lodish: Synergistic cooperation of TFE3 and Smad proteins in TGF-beta-induced transcription of the plasminogen activator inhibitor-1 gene. Genes Dev 12, 3084-3095 (1998)
94. Hua X., Z.A. Miller, G. Wu, Y. Shi & H.F. Lodish: Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: Interactions of promoter DNA, transcription factor mu E3, and Smad proteins. Proc Natl Acad Sci USA 96, 13130-13135 (1999)
95. Zhang Y., X.H. Feng & R. Derynck: Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394, 909-912 (1998)
96. Qing J., Y. Zhang & R. Derynck: Structural and functional characterization of the transforming growth factor-beta-induced Smad3/c-Jun transcriptional cooperativity. J Biol Chem 275, 38802-38812 (2000)
97. Wong C., E.M. Rougier-Chapman, J.P. Frederick, M.B. Datto, N.T. Liberati, J.M. Li & X.F. Wang: Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol Cell Biol 19, 1821-1830 (1998)
98. Hanai J., L.F. Chen, T. Kanno, N. Ohtani-Fujita, W.Y. Kim, W.-H. Guo, T. Imamura, Y. Ishidou, M. Fukuchi, M.-J. Shi, J. Stavnezer, M. Kawabata, K. Miyazono & Y. Ito: Interaction and functional cooperation of PEBP2/CBF with Smads: Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 274, 31577-31582 (1999)
99. Pardali E., X.-Q. Xie, P. Tsapogas, S. Itoh, K. Arvanitidis, C.-H. Heldin, P. ten Dijke, T. Grundström & P. Sideras: Smad and AML proteins synergistically confer transforming growth factor-beta 1 responsiveness to human germ-line IgA genes. J Biol Chem 275, 3552-3560 (2000)
100. Zhang Y. & R. Derynck: Transcriptional regulation of the transforming growth factor-beta-inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J Biol Chem 275, 16979-16985 (2000)
101. Jonk L.J., S. Itoh, C.-H. Heldin, P. ten Dijke & W. Kruijer: Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem 273, 21145-21152 (1998)
102. Johnson K., H. Kirkpatrick, A. Comer, F.M. Hoffmann & A. Laughon: Interaction of Smad complexes with tripartite DNA-binding sites. J Biol Chem 274, 20709-20716 (1999)
103. Hata A., J. Seoane, G. Lagna, E. Montalvo, A. Hemmati-Brivanlou & J. Massagué: OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways. Cell 100, 229-40 (2000)
104. Kim J., K. Johnson, H.J. Chen, S. Carroll & A. Laughon: Drosophila MAD binds to DNA and directly mediates activation of vestigial by decapentaplegic. Nature 388, 304-308 (1997)
105. Labbé E., C. Silvestri, P.A. Hoodless, J.L. Wrana & L. Attisano: Smad2 and Smad3 positively and negatively regulate TGFbeta-dependent transcription through the forkhead DNA-Binding protein FAST2. Mol Cell 2, 109-120 (1998)
106. Kusanagi K., H. Inoue, Y. Ishidou, H.K. Mishima, M. Kawabata & K. Miyazono: Characterization of a bone morphogenetic protein-responsive Smad-binding element. Mol Biol Cell 11, 555-565 (2000)
107. Chen X., M.J. Rubock & M. Whitman: A transcriptional partner for MAD proteins in TGF-beta signaling. Nature 383, 691-696 (2000)
108. Chen X., E. Weisberg, V. Fridmacher, M. Watanabe, G. Naco & M. Whitman: Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389: 85-89 (1997)
109. Yeo C.Y., X. Chen & M. Whitman: The role of FAST-1 and Smads in transcriptional regulation by activin during early Xenopus embryogenesis. J Biol Chem 274, 26584-26590 (1999)
110. Sano Y., J. Harada, S. Tashiro, R. Gotoh-Mandeville, T. Maekawa & S. Ishii: ATF-2 Is a common nuclear target of Smad and TAK1 pathways in transforming growth factor-beta signaling. J Biol Chem 274, 8949-8957 (1999)
111. Hanafusa H., J. Ninomiya-Tsuji, N. Masuyama, M. Nishita, J.-I. Fujisawa, H. Shibuya, K. Matsumoto & E. Nishida: Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta induced gene expression. J Biol Chem 274, 27161-27167 (1999)
112. Liberati N.T., M.B. Datto, J.P. Frederick, X. Shen, C. Wong, E.M. Rougier-Chapman & X.-F. Wang: Smads bind directly to the Jun family of AP-1 transcription factors. Proc Natl Acad Sci USA 96, 4844-4849 (1999)
113. Kardassis D., K. Pardali & V.I. Zannis: SMAD proteins transactivate the human ApoCIII promoter by interacting physically and functionally with hepatocyte nuclear factor 4. J Biol Chem 275, 41405-41414 (2000)
114. Labbé E., A. Letamendia & L. Attisano: Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and Wnt pathways. Proc Natl Acad Sci USA 97, 8358-8363 (2000)
115. Nishita M., M.K. Hashimoto, S. Ogata, M.N. Laurent, N. Ueno, H. Shibuya & K.W.Y. Cho: Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 403, 781-785 (2000)
116. Quinn Z.A., C.C. Yang, J.L. Wrana & J.C. McDermott: Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins. Nucleic Acids Res 29, 732-742 (2001)
117. Kaji H., L. Canaff, J.J. Lebrun, D. Goltzman, G.N. Hendy: Inactivation of menin, a Smad3-interacting protein, blocks transforming growth factor type beta signaling. Proc Natl Acad Sci USA 2001 98, 3837-3842 (2001)
118. Germain S., M. Howell, G.M. Esslemont & C.S. Hill: Homeodomain and winged-helix transcription factors recruit activated Smads to distinct promoter elements via a common Smad interaction motif. Genes Dev 14, 435-451 (2000)
119. Randall R.A., S. Germain, G.J. Inman, P.A. Bates & C.S. Hill: Different Smad2 partners bind a common hydrophobic pocket in Smad2 via a defined proline-rich motif. EMBO J 21, 145-156 (2002)
120. Lopez-Rovira T., E. Chalaux, J.L. Rosa, R. Bartrons & F. Ventura: Interaction and functional cooperation of, NF-kappaB, with Smads: transcriptional regulation of the JunB promoter. J Biol Chem 275, 28937-28946 (2000)
121. Moustakas A. & D. Kardassis: Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interaction between Sp1 and Smad family members. Proc Natl Acad Sci USA 95, 6733-6738 (1998)
122. Waf1/Cip1 regulation by transforming growth factor-β. J Biol Chem 275, 29244-29256 (2000)
123. Ink4B transcription in response to TGF-beta. EMBO J 19, 5178-5193 (2000)
124. Lai C.F., X. Feng, R. Nishimura, S.L. Teitelbaum, L.V. Avioli, F.P. Ross & S.L. Cheng: Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem 275, 36400-36406 (2000)
125. Shimizu K., P.Y. Bourillot, S.J. Nielsen, A.M. Zorn & J.B. Gurdon: Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling. Mol Cell Biol 12, 3901-3912 (2001)
126. Yanagisawa J., Y. Yanagi, Y. Masuhiro, M. Suzawa, M. Watanabe, K. Kashiwagi, T. Toriyabe, M. Kawabata, K. Miyazono & S. Kato: Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321 (1999)
127. Yanagi Y., M. Suzawa, M. Kawabata, K. Miyazono, J. Yanagisawa & S. Kato: Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 274, 12971-12974 (1999)
128. Hayes S.A., M. Zarnegar, M. Sharma, F. Yang, D.M. Peehl, P. ten Dijke & Z. Sun: SMAD3 represses androgen receptor-mediated transcription. Cancer Res 61, 2112-2118 (2001)
129. Kang H.Y., H.K. Lin, Y.C. Hu, S. Yeh, K.E. Huang & C. Chang: From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci USA 98, 3018-3023 (2001)
130. Chipuk J.E., S.C. Cornelius, N.J. Pultz, J.S. Jorgensen, M.J. Bonham, S.J. Kim & D. Danielpour: The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3. J Biol Chem 277,1240-1248 (2002)
131. Kang H.Y., K.E. Huang, S.Y. Chang, W.L. Ma, W.J. Lin & C. Chang: Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277, 43749-43756 (2002)
132. Dou C., J. Lee, B. Liu, F. Liu, J. Massague, S. Xuan & E. Lai: BF-1 interferes with transforming growth factor beta signaling by associating with Smad partners. Mol Cell Biol 20, 6201 -6211 (2000)
133. Rodriguez C., L.J. Huang, J.K. Son, A. McKee, Z. Xiao & H.F. Lodish: Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-beta signaling. J Biol Chem 276, 30224-30230 (2001)
134. Nishihara A., J. Hanai, T. Imamura, K. Miyazono & M. Kawabata: E1A inhibits transforming growth factor-beta signaling through binding to Smad proteins. J Biol Chem 274, 28716-28723 (1999)
135. Matsuda T., T. Yamamoto, A. Muraguchi & F. Saatcioglu: Cross-talk between transforming growth factor-beta and estrogen receptor signaling through Smad3. J Biol Chem 276, 42908-42914 (2001)
136. Kurokawa M., K. Mitani, K. Irie, T. Matsuyama, T. Takahashi, S. Chiba, Y. Yazaki, K. Matsumoto & H. Hirai: The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3. Nature 394, 92-96 (1998)
137. Kurokawa M., K. Mitani, Y. Imai, S. Ogawa, Y. Yazaki & H. Hirai: The t(3;21) fusion product, AML1/Evi1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood 92, 4003-4012 (1998)
138. Izutsu K, M. Kurokawa, Y. Imai, K. Maki, K. Mitani & H. Hirai: The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling. Blood 97, 2815-2822 (2001)
139. Song C.Z., X. Tian, & T.D. Gelehrter: Glucocorticoid receptor inhibits transforming growth factor-beta transcriptional activation function of Smad3. Proc Natl Acad Sci USA 96, 11776-11781 (1999)
140. Liu F., J. Massague & A. Ruiz i Altaba: Carboxy-terminally truncated Gli3 proteins associate with Smads. Nat Genet 20, 325-326 (1998)
141. Verschueren K., J.E. Remade, C. Collart, H. Kraft, B.S. Baker, P. Tylzanowski, L. Nelles, G. Wuytens, M.-T. Su, R. Bodmer, J.C. Smith & D. Huylebroeck: SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J Biol Chem 274, 20489-20498 (1999)
142. Kim R.H., D. Wang, M. Tsang, J. Martin, C. Huff, M.P. de Caestecker, W.T. Parks, X. Meng, R.J. Lechleider, T. Wang, & A.B. Roberts: A novel Smad nuclear interacting protein (SNIP1) suppresses p300-dependent TGF-beta signal transduction. Genes Dev 14,1605-1616 (2000)
143. Pick E., W.J. Ju, J. Heyer, D. Escalante-Alcalde, C.L. Stewart, M. Weinstein, C. Deng, R. Kucherlapati, E.P. Bottinger & A.B. Roberts: Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J Biol Chem 276, 19945-19953 (2001)
144. Liu F., A. Hata, J.C. Baker, J. Doody, J. Carcamo, R.M. Harland & J. Massague: A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996)
145. Feng X.H., Y. Zhang, R.Y. Wu & R. Derynck: The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation. Gene Dev 12, 2153-2163 (1998)
146. Janknecht R., N.J. Wells & T. Hunter: TGF-beta-stimulated cooperation of smad proteins with the coactivators CBP/p300. Gene Dev 12, 2114-2119 (1998)
147. Pouponnot C., L. Jayaraman & J. Massague: Physical and functional interaction of SMADs and p300/CBP. J Biol Chem 273, 22865-22868 (1998)
148. Topper J.N., M.R. DiChiara, J.D. Brown, A.J. Williams, D. Falb, T. Collins & M.A. Gimbrone Jr.: CREB binding protein is a required coactivator for Smad-dependent, transforming growth factor beta transcriptional responses in endothelial cells. Proc Natl Acad Sci USA 95, 9506-9511 (1998)
149. Shen X., P.P. Hu, N.T. Liberati, M.B. Datto, J.P. Frederick & X.F. Wang: TGF-beta-induced phosphorylation of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol Biol Cell 9, 3309-3319 (1998)
150. Nishihara A., J.I. Hanai, N. Okamoto, J. Yanagisawa, S. Kato, K. Miyazono & M. Kawabata: Role of p300, a transcriptional coactivator, in signalling of TGF-beta. Genes Cells 3, 613-623 (1998)
151. Itoh S., J. Ericsson, J. Nishikawa, C.-H. Heldin & P. ten Dijke: The transcriptional co-activator P/CAF potentiates TGF-beta/Smad signaling. Nucleic Acids Res 28, 4291-4298 (2000)
152. de Caestecker M.P., T. Yahata, D. Wang, W.T. Parks, S. Huang, C.S. Hill, T. Shioda, A.B. Roberts & R.J. Lechleider: The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem 275, 2115-2122 (2000)
153. Qin B., S.S.W. Lam & K. Lin: Crystal structure of a transcriptionally active Smad4 fragment. Structure 7,1493-1503 (1999)
154. Shioda T, R.J. Lechleider, S.L. Dunwoodie, H. Li, T. Yahata, M.P. de Caestecker, M.H. Fenner, A.B. Roberts & K.J. Isselbacher: Transcriptional activating activity of Smad4: roles of SMAD hetero-oligomerization and enhancement by an associating transactivator. Proc Natl Acad Sci USA 95, 9785-9790 (1998)
155. Yahata T., M.P. de Caestecker, R.J. Lechleider, S. Andriole, A.B. Roberts, K.J. Isselbacher & T. Shioda: The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J Biol Chem 275, 8825-8834 (2000)
156. Bai R.Y., C. Koester, T. Ouyang, S.A. Hahn, M. Hammerschmidt, C. Peschel & J. Duyster: SMIF, a Smad4-interacting protein that functions as a co-activator in TGFbeta signalling. Nat Cell Biol 4, 181-190 (2002)
157. Callebaut I.: An EVH1/WH1 domain as a key actor in TGFbeta signalling. FEBS Lett 519, 178-180 (2002)
158. Wotton D., R.S. Lo, S. Lee & J. Massagué: A Smad transcriptional corepressor. Cell 91, 29-39 (1999)
159. Wotton D., R.S. Lo, L.A. Swaby, J. Massague: Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 274, 37105-37110 (1999)
160. Wotton D., P.S. Knoepfler, C.D. Laherty, R.N. Eisenman & J. Massague: The Smad transcriptional corepressor TGIF recruits mSin3. Cell Growth Differ 12, 457-463 (2001)
161. Melhuish T.A. & D. Wotton: The interaction of the carboxyl terminus-binding protein with the Smad corepressor TGIF is disrupted by a holoprosencephaly mutation in TGIF. J Biol Chem 275, 39762-39766 (2000)
162. Gripp K.W., D. Wotton, M.C. Edwards, E. Roessler, L. Ades, P. Meinecke, A. Richieri-Costa, E.H. Zackai, J. Massague, M. Muenke & S.J. Elledge: Mutations in TGIF cause holoprosencephaly and link NODAL signalling to human neural axis determination. Nat Genet 25, 205-208 (2000)
163. Lo R.S., D. Wotton & J. Massague: Epidermal growth factor signaling via Ras controls the Smad transcriptional co-repressor TGIF. EMBO J 20, 128-136 (2001)
164. Nomura T., M.M. Khan, S.C. Kaul, H.D. Dong, R. Wadhwa, C. Colmenares, I. Kohno & S. Ishii: Ski is a component of the histone deacetylase complex required for transcriptional repression by Mad and thyroid hormone receptor. Genes Dev 13, 412-423 (1999)
165. Luo K., S.L. Stroschein, W. Wang, D. Chen, E. Martens, & Q. Zhou: The ski oncoprotein interacts with the smad proteins to repress TGF-beta signaling. Genes Dev 13, 2196-2206 (1999)
166. Dai P., T. Shinagawa, T. Nomura, J. Harada, S.C. Kaul, R. Wadhwa, M.M. Khan, H. Akimaru, H. Sasaki, C. Colmenares & S. Ishii: Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3. Genes Dev 16, 2843-2848 (2002)
167. Sun Y., X. Liu, E.N. Eaton, W.S. Lane, H.F. Lodish & R.A. Weinberg: Interaction of the Ski oncoprotein with Smad3 regulates TGF-beta signaling. Mol Cell 4, 499-509 (1999)
168. Akiyoshi S., H. Inoue, J. Hanai, K. Kusanagi, N. Nemoto, K. Miyazono & M. Kawabata: c-Ski acts as a transcriptional co-repressor in transforming growth factor-beta signaling through interaction with smads. J Biol Chem 274, 35269-35277 (1999)
169. Stroschein S.L., W. Wang, S. Zhou, Q. Zhou & K. Luo: Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein. Science 286, 771-774 (1999)
170. Sun Y., X. Liu, E. Ng-Eaton, H.F. Lodish & R.A. Weinberg: SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor signaling. Proc Natl Acad Sci USA 96, 12442-12447 (1999)
171. Xu W., K. Angelis, D. Danielpour, M.M. Haddad, O. Bischof, J. Campisi, E. Stavnezer & E.E. Medrano: Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci USA 97, 5924-5929 (2000)
172. Wu J.W., A.R. Krawitz, J. Chai, W. Li, F. Zhang, K. Luo & Y. Shi: Structural mechanism of Smad4 recognition by the nuclear oncoprotein Ski: insights on Ski-mediated repression of TGF-beta signaling. Cell 111, 357-367 (2002)
173. Alliston T., L. Choy, P. Ducy, G. Karsenty & R. Derynck: TGF-β-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 20, 2254-2272 (2001)
174. Liu D., B.L. Black & R. Derynck: TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev 15, 2950-2966 (2001)
175. Liberati N.T., M. Moniwa, A.J. Borton, J.R. Davie & X.F. Wang: An essential role for Mad homology domain 1 in the association of Smad3 with histone deacetylase activity. J Biol Chem 276, 22595-22603 (2001)
176. Hershko A. & A. Ciechanover: The ubiquitin system. Annu Rev Biochem 67, 425-479 (1998)
177. Arora K. & R. Warrior: A new Smurf in the village. Dev Cell 1, 441-442 (2001)
178. Miyazono K.: A new partner for inhibitory Smads. Cytokine Growth Factor Rev 13, 7-9 (2002)
179. Zhu H., P. Kavsak, S. Abdollah, J.L. Wrana & G.H. Thomsen: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693 (1999)
180. Lin X., M. Liang & X.H. Feng: Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 275, 36818-3622 (2000)
181. Zhang Y., C. Chang, D.J. Gehling, A. Hemmati-Brivanlou & R. Derynck: Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci USA 98, 974-979 (2001)
182. Lo R.S. & J. Massague: Ubiquitin-dependent degradation of TGF-beta-activated Smad2. Nat Cell Biol 1, 472-478 (1999)
183. Fukuchi M., T. Imamura, T. Chiba, T. Ebisawa, M. Kawabata, K. Tanaka & K. Miyazono: Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol Biol Cell 12, 1431-1443 (2001)
184. Kavsak P., R.K. Rasmussen, C.G. Causing, S. Bonni, H. Zhu, G.H. Thomsen & J.L. Wrana: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF-beta receptor for degradation. Mol Cell 6,1365-1375 (2000)
185. Ebisawa T., M. Fukuchi, G. Murakami, T. Chiba, K. Tanaka, T. Imamura & K. Miyazono: Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 276, 12477-12480 (2001)
186. Bonni S., H.R. Wang, C.G. Causing, P. Kavsak, S.L. Stroschein, K. Luo & J.L.Wrana: TGF-beta induces assembly of a Smad2-Smurf2 ubiquitin ligase complex that targets SnoN for degradation. Nat Cell Biol 3, 587-595 (2001)
187. Stroschein S.L., S. Bonni, J.L. Wrana & K. Luo: Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN. Genes Dev 15, 2822-2836 (2001)
188. Wan Y., X. Liu & M.W. Kirschner: The anaphase-promoting complex mediates TGF-beta signaling by targeting SnoN for destruction. Mol Cell 8,1027-1039 (2001)
189. Liu X., A.E. Elia, S.F. Law, E.A. Golemis, J. Farley & T. Wang: A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1. EMBO J 19, 6759-6769 (2000)
190. Xu J. & L. Attisano: Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 97, 4820-4825 (2000)
191. Morén A., S. Itoh, A. Moustakas, P. ten Dijke & C.H. Heldin: Functional consequences of tumorigenic missense mutations in the amino-terminal domain of Smad4. Oncogene 19, 4396-4404 (2000)
192. Maurice D., C.E. Pierreux, M. Howell, R.E. Wilentz, M.J. Owen & C.S. Hill: Loss of Smad4 function in pancreatic tumors: C-terminal truncation leads to decreased stability. J Biol Chem 276, 43175-43181 (2001)
193. Saha D., P.K. Datta & R.D. Beauchamp: Oncogenic ras represses transforming growth factor-beta/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem 276, 29531-29537 (2001)
194. de Caestecker M.P., W.T. Parks, C.J. Frank, P. Castagnino, D.P. Bottaro, A.B. Roberts, & R.J. Lechleider: Smad2 transduces common signals from receptor serine-threonine and tyrosine kinases. Genes Dev 12, 1587-1592 (1998)
195. Blanchette F., N. Rivard, P. Rudd, F. Grondin, L. Attisano & C.M. Dubois: Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J Biol Chem 276, 33986-33994 (2001)
196. Kretzschmar M., J. Doody & J. Massagué: Opposing BMP and EGF signalling pathway converge on the TGF-beta family mediator Smad1. Nature 389, 618-622 (1997)
197. Kretzschmar M., J. Doody, I. Timokhina & J. Massagué: A mechanism of repression of TGF-beta/Smad signaling by ongenic ras. Genes Dev 13, 804-816 (1999)
198. Hu P.P., X. Shen, D. Huang, Y. Liu, C. Counter & X.F. Wang: The MEK pathway is required for stimulation of p21(WAF1/CIP1) by transforming growth factor-beta. J Biol Chem 274, 35381-35387 (1999)
199. Lehmann K., E. Janda, C.E. Pierreux, M. Rytomaa, A. Schulze, M. McMahon, C.S. Hill, H. Beug & J. Downward: Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Gene Dev 14, 2610-2622 (2000)
200. Yue J. & K.M. Mulder: Requirement of Ras/MAPK pathway activation by transforming growth factor beta for transforming growth factor beta 1 production in a Smad-dependent pathway. J Biol Chem 275, 30765-30773 (2000)
201. Mulder K.M.: Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev 11, 23-35 (2000)
202. Zimmerman C.M., Kariapper M.S. & L.S. Mathews: Smad proteins physically interact with calmodulin. J Biol Chem 273, 677-680 (1998)
203. Scherer A. & J.M. Graff: Calmodulin differentially modulates Smad1 and Smad2 signaling. J Biol Chem 275, 41430-41438 (2000)
204. Hocevar B.A., T.L. Brown & P.H. Howe: TGF-beta induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. EMBO J 18, 1345-1356 (1999)
205. Brown J.D., M.R. DiChiara, K.R. Anderson, M.A. Gimbrone, Jr. & J.N. Topper: MEKK-1, a component of the stress (stress-activated protein kinase/c-Jun N-terminal kinase) pathway, can selectively activate Smad2-mediated transcriptional activation in endothelial cells. J Biol Chem 274, 797-805 (1999)
206. Engel M.E., M.A. McDonnell, B.K. Law & H.L. Moses: Interdependent SMAD and JNK signaling in transforming growth factor-beta-mediated transcription. J Biol Chem 274, 37413-37420 (1999)
207. Yamaguchi K., K. Shirakabe, H. Shibuya, K. Irie, I. Oishi, N. Ueno, T. Taniguchi, E. Nishida & K. Matsumoto: Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 270, 2008-2011 (1995)
208. Yu L., M.C. Hebert & Y.E. Zhang: TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses. EMBO J 21, 3749-3759 (2002)
209. Takekawa M., K. Tatebayashi, F. Itoh, M. Adachi, K. Imai & H. Saito: Smad-dependent GADD45beta expression mediates delayed activation of p38 MAP kinase by TGF-beta. EMBO J 21, 6473-6482 (2002)
210. Wicks S.J., S. Lui, N. Abdel-Wahab, R.M. Mason & A. Chantry: Inactivation of Smad-transforming growth factor beta signaling by Calcium-calmodulin-dependent protein kinase II. Mol Cell Biol 20, 8103-8111 (2000)
211. Yakymovych I., P. ten Dijke, C.-H. Heldin & S. Souchelnytskyi: Regulation of Smad signaling by protein kinase C. FASEB J 15, 553-555 (2001)
212. Weinstein M., X. Yang & C.X. Deng: Functions of mammalian Smad genes as revealed by targeted gene disruption in mice. Cytokine Growth Factor Rev 11, 49-58 (2000)
213. Datto M. & X.F. Wang: The Smads: transcriptional regulation and mouse models. Cytokine Growth Factor Rev 11, 37-48 (2000)
214. Weinstein M., X. Yang, C. Li, X. Xu, J. Gotay & C.X. Deng: Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor Smad2. Proc Natl Acad Sci USA 95, 9378-9383 (1998)
215. Nomura M. & E. Li: Smad2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393, 786-790 (1998)
216. Waldrip W.R., E.K. Bikoff, P.A. Hoodless, J.L. Wrana & E.J. Robertson: Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92, 797-808 (1998)
217. Heyer J., D. Escalante-Alcalde, M. Lia, E. Boettinger, W. Edelmann, C.L. Stewart & R. Kucherlapati: Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. Proc Natl Acad Sci USA 96, 12595-12600 (1999)
218. Sirard C., J.L. de la Pompa, A. Elia, A. Itie, C. Mirtsos, A. Cheung , S. Hahn, A. Wakeham, L. Schwartz, S.E. Kern, J. Rossant & T.W. Mak: The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev 12, 107-119 (1998)
219. Yang X., X. Li, X. Xu & C.X. Deng: The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc Natl Acad Sci USA 95, 3667-3672 (1998)
220. Yang X., J.J. Letterio, R.J. Lechleider, L. Chen, R. Hayman, H. Gu, A.B. Roberts & C.X. Deng: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J 18, 1280-1291 (1999)
221. Zhu Y., J.A. Richardson, L.F. Parada & J.M. Graff: Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714 (1999)
222. Datto M.B., J.P. Frederick, L. Pan, A.J. Borton, Y. Zhuang & X.F. Wang: Targeted disruption of Smad3 reveals an essential role in transforming growth factor β-mediated signal transduction. Mol Cell Biol 19, 2495-2504 (1999)
223. INK4B induction and growth inhibition in astrocytes is Smad3-dependent and a pathway prominently altered in human glioma cell lines. J Biol Chem 274, 35053-35058 (1999)
224. Ashcroft G.S., X. Yang, A.B. Click, M. Weinstein, J.L. Letterio, D.E. Mizel, M. Anzano, T. Greenwell-Wild, S.M. Wahl, C. Deng & A.B. Roberts: Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response. Nat Cell Biol 1, 260-266 (1999)
225. Ashcroft G.S. & A.B. Roberts: Loss of Smad3 modulates wound healing. Cytokine Growth Factor Rev 11, 125-131 (2000)
226. Yang X., L. Chen, X. Xu, C. Li, C. Huang & C.X. Deng: TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153, 35-46 (2001)
227. Eppert K., S.W. Scherer, H. Ozcelik, R. Pirone, P. Hoodless, H. Kim, L.-C. Tsui, B. Bapat, S. Gallinger, I.L. Andrulis, G.H. Thomsen, J.L. Wrana & L. Attisano: MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86, 543-552 (1996)
228. Riggins G.J., S. Thiagalingam, E. Rozenblum, C.L. Weinstein, S.E. Kern, S.R. Hamilton, J.K.V. Willson, S.D. Markowitz, K.W. Kinzler & B. Vogelstein: Mad-related genes in the human. Nature Genet 13, 347-349 (1996)
229. Hahn S.A., M. Schutte, A.T.M.S. Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban & S.E. Kern: DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996)
230. Barrett M.T., M. Schutte, S.E. Kern & B.J. Reid: Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res 56, 4351-4353 (1996)
231. Kim S.K., Y. Fan, V. Papadimitrakopoulou, G. Clayman, W.N. Hittelman, W.K. Hong, R. Lotan & L. Mao: DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res 56, 2519-2521 (1996)
232. Nagatake M., Y. Takagi, H. Osada, K. Uchida, T. Mitsudomi, S. Saji, K. Shimokata, T. Takahashi & T. Takahashi: Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res 56, 2718-2720 (1996)
233. Schutte M., R.H. Hruban, L. Hedrik, K.R. Cho, G.M. Nadasdy, C.L. Weinstein, G.S. Bova, W.B. Isaacs, P. Cairns, H. Nawroz, D. Sidransky, C.A. Casero, P.S. Meltzer, S.A. Hahn & S.E. Kern: DPC4 gene in various tumor types. Cancer Res 56, 2527-2530 (1996)
234. Liu F.: SMAD4/DPC4 and pancreatic cancer survival. Clin Cancer Res 7, 3853-3856 (2001)
235. Goto D., K. Yagi, H. Inoue, I. Iwamoto, M. Kawabata, K. Miyazono & M. Kato: A single missense mutant of Smad3 inhibits activation of both Smad2 and Smad3, and has a dominant negative effect on TGF-beta signals. FEBS Lett 430, 201-204 (1998)
236. Hamamoto T., H. Beppu, H. Okada, M. Kawabata, T. Kitamura, K. Miyazono & M. Kato: Compound disruption of smad2 accelerates malignant progression of intestinal tumors in ape knockout mice. Cancer Res 62, 5955-5961 (2002)
237. Takaku K., J.L. Wrana, E.J. Robertson & M.M. Taketo: No effects of Smad2 (madh2) null mutation on malignant progression of intestinal polyps in Apc(delta716) knockout mice. Cancer Res 62, 4558-4561 (2002)
238. Takaku K., M. Oshima, H. Miyoshi, M. Matsui, M.F. Seldin & M.M. Taketo: Intestinal tumorigenesis in compound mutant mice of both Dpc4 (Smad4) and Apc genes. Cell 92, 645-656 (1998)
239. Xu X., S.G. Brodie, X. Yang, Y.H. Im, W.T. Parks, L. Chen, Y.X. Zhou, M. Weinstein, S.J. Kim & C.X. Deng: Haploid loss of the tumor suppressor Smad4/Dpc4 initiates gastric polyposis and cancer in mice. Oncogene 19, 1868-1874 (2000)
240. Arai T., Y. Akiyama, S. Okabe, M. Ando, M. Endo & Y. Yuasa: Genomic structure of the human Smad3 gene and its infrequent alterations in colorectal cancers. Cancer Lett 122, 157-63 (1998)
241. Philipp-Staheli J., K.H. Kim, S.R. Payne, K.E. Gurley, D. Liggitt, G. Longton & C.J. Kemp: Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice. Cancer Cell 1, 355-368 (2002)
242. Sherr C.J.: Cancer cell cycles. Science 274, 1672-1677 (1996)
243. Hall M. & G. Peters: Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68, 67-108 (1996)
244. Sherr C.J. & J.M. Roberts: CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13, 1501-1512 (1999)
245. Koff A., M. Ohtsuki, K. Polyak, J.M. Roberts & J. Massagué: Negative regulation of G1 in mammalian cells: inhibition of cyclin E-dependent kinase by TGF-beta. Science 260, 536-539 (1993)
246. Pietenpol J.A., R.W. Stein, E. Moran, P. Yaciuk, R. Schlegel, R.M. Lyons, M.R. Pittelkow, K. Munger, P.M. Howley & H.L. Moses: TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 61, 777-785 (1990)
247. Pietenpol J.A., J.T. Holt, R.W. Stein & H.L. Moses: Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87, 3758-3762 (1990)
248. Pietenpol J.A., K. Munger, P.M. Howley, R.W. Stein & H.L. Moses: Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. Proc Natl Acad Sci USA 88, 10227-10231 (1991)
249. Alexandrow M.G. & H.L. Moses: Transforming growth factor-beta and cell cycle regulation. Perspect Cancer Res 55, 1452-1457 (1995)
250. Iavarone A. & J. Massague: Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387, 417-422 (1997)
251. Hannon G.J. & D. Beach: p15INK4b is a potential effector of TGF-beta induced cell cycle arrest. Nature 371, 257-261 (1994)
252. INK4B through an Sp1 consensus site. J Biol Chem 270, 26750-26753 (1995)
253. Datto M.B., Y. Li, J.F. Panus, D.J. Howe, Y. Xiong & X.F. Wang: Transforming growth factor beta induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism. Proc Natl Acad Sci USA 92, 5545-5549 (1995)
254. Datto M.B., Y. Yu & X.F. Wang: Functional analysis of the transforming growth factor β responsive elements in the WAF1/Cip1/p21 promoter. J Biol Chem 270, 28623-28628 (1995)
255. Warner B.J., S.W. Blain, J. Seoane & J. Massague: Myc downregulation by transforming growth factor beta required for activation of the p15(Ink4b) G1 arrest pathway. Mol Cell Biol 19, 5913-5922 (1999)
256. Claassen G.F. & S.R. Hann: A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta-induced cell-cycle arrest. Proc Natl Acad Sci USA 97, 9498-9503 (2000)
257. Chen C.R., Y. Kang & J. Massagué: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor growth arrest program. Proc Natl Acad Sci USA 98, 992-999 (2001)
258. Yagi K., M. Furuhashi, H. Aoki, D. Goto, H. Kuwano, K. Sugamura, K. Miyazono & M. Kato: c-myc is a downstream target of the Smad pathway. J Biol Chem 277, 854-861 (2002)
259. Chen C.-R., Y. Kang, P.M. Siegel & J. Massague: E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110,19-32 (2002)
260. Staller P., K. Peukert, A. Kiermaier, J. Seoane, J. Lukas, H. Karsunky, T. Moroy, J. Bartek, J. Massague, F. Hanel & M. Eilers: Repression of p15INK4b expression by Myc through association with Miz-1. Nat Cell Biol 3, 392-399 (2001)
261. Seoane J., C. Pouponnot, P. Staller, M. Schader, M. Eilers & J. Massague: TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat Cell Biol 3, 400-408 (2001)
262. Seoane J., H.V. Le & J. Massague: Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002)
263. Feng X.H., Y.Y. Liang, M. Liang, W. Zhai & X. Lin: Direct interaction of c-Myc with Smad2 and Smad3 to inhibit TGF-beta-mediated induction of the CDK inhibitor p15(Ink4B). Mol Cell 9, 133-143 (2002)
264. Ziegelbauer J., B. Shan, D. Yager, C. Larabell, B. Hoffmann & R. Tjian: Transcription factor MIZ-1 is regulated via microtubule association. Mol Cell 8, 339-349 (2001)
265. Reynisdot́tir I., K. Polyak, A. Iavarone & J. Massagué: Kip/Cip and Ink4 cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta. Genes Dev 9, 1831-1845 (1995)
266. Reynisdóttir I. & J. Massagué: The subcellular locations of p15INK4b and p27Kip1 coordinate their inhibitory interactions with cdk4 and cdk2. Genes Dev 11, 492-503 (1997)
267. Penheiter S.G., H. Mitchell, N. Garamszegi, M. Edens, J.J. Doré Jr. & E.B. Leof: Internalization-dependent and -independent requirements for transforming growth factor receptor signaling via the Smad pathway. Mol Cell Biol 22, 4750-4759 (2002)
268. Lu Z., J.T. Murray, W. Luo, H. Li, X. Wu, H. Xu, J.M. Backer & Y.G. Chen: Transforming growth factor beta activates Smad2 in the absence of receptor endocytosis. J Biol Chem 277, 29363-29368 (2002)
269. Akiyoshi S., M. Ishii, N. Nemoto, M. Kawabata, H. Aburatani & K. Miyazono: Targets of transcriptional regulation by transforming growth factor-β: expression profile analysis using oligonucleotide arrays. Jpn J Cancer Res 92, 257-268 (2001)
270. Zavadil J., M. Bitzer, D. Liang, Y.C. Yang, A. Massimi, S. Kneitz, E. Piek & E.P. Böttinger: Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 98, 6686-6691 (2001)
271. Verrecchia F., M.L. Chu & A. Mauviel: Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach. J Biol Chem 276, 17058-17062 (2001)
272. Sirard C., S. Kim, C. Mirtsos, P. Tadich, P.A. Hoodless, A. Itie, R. Maxson, J.L. Wrana & T.W. Mak: Targeted disruption in murine cells reveals variable requirement for Smad4 in transforming growth factor beta-related signaling. J Biol Chem 275, 2063-2070 (2000)